Schilling test

From Aaushi
Jump to navigation Jump to search

Indications

Procedure

Stage I.

Tests the ability to absorb cobalamin from the small intestine. The patient is given a 0.5-2.0 ug oral dose of radiolabeled cobalamin in a fasting state, followed in 2 hours by a large parenteral dose of unlabeled cobalamin in order to saturate the tissue-binding sites. Saturation allows the absorbed radiolabeled cobalamin to be excreted in the urine. Radioactivity is measured in the urine collected over the next 24 hours. Normal levels of radioactivity in the urine (> 7% of a 1 ug dose) indicate normal absorption of cobalamin. An abnormally low level of radioactivity in the urine indicates poor absorption & the need for Stage II testing.

Stage II.

Tests whether lack of intrinsic factor is the cause of cobalamin deficiency. The test is repeated, but this time the oral dose is given together with intrinsic factor (hog or recombinant). Normal radioactivity in the 24 hour urine specimen indicates a lack of intrinsic factor is the cause of the patient's cobalamin deficiency. Low urine radioactivity in Stage II testing indicates intestinal malabsorption.

Stage III

Test is conducted after a course of treatment with antibiotics or anti-inflammatory agents.

Stage IV

In patients with inflammatory diseases affecting the terminal ileum, the ileal receptor site for intrinsic factor may be damaged. The Schilling test may normalize after treatment with prednisone or sulfasalazine.

Stage V

Some patients may absorb vitamin B12 in water as in the Schilling test, but not in food bound to protein. A modification of the Schilling test using vitamin B12 bound to egg albumin in Stage I testing may be useful.

Interpretation

Distinguishing features of malabsorption syndromes

Disorder Co-58 IF Pancreatic Enzymes Antibiotics
pernicious anemia low normal low low
chronic anemia low low normal low
bacterial overgrowth low low low normal
ileal disease low low low low

Co-58: Stage 1 (excretion of Co-58 in urine)

IF: Stage 2 (addition of intrinsic factor)

Pancreatic Enzymes: as in stage 2, but inclusion of pancreatic enzymes rather than intrinsic factor

Antibiotics: Stage 3 (after 5 day treatment with antibiotics)

More general terms

Additional terms

References

  1. Tietz et al Applied Laboratory Medicine, WB Saunders, Philadelphia, 1992, pg 528
  2. Clinical Diagnosis & Management by Laboratory Methods, 19th edition, J.B. Henry (ed), W.B. Saunders Co., Philadelphia, PA. 1996
  3. Harrison's Online, Chapter 286, McGraw-Hill, 2003